Literature DB >> 14718260

Impact of treatment with melatonin on cerebral circulation in old rats.

François Dupuis1, Olivier Régrigny, Jeffrey Atkinson, Patrick Limiñana, Philippe Delagrange, Elizabeth Scalbert, Jean-Marc Chillon.   

Abstract

Melatonin deprival in young rats induces alterations in cerebral arteriolar wall similar to those observed during aging: atrophy and a decrease in distensibility. In this study, we examined the effects of melatonin treatment on cerebral arteriolar structure and distensibility and on the lower limit of cerebral blood flow autoregulation (LLCBF) in old rats. We measured cerebral blood flow (arbitrary unit, laser Doppler, open skull preparation) prior to and during stepwise hypotension (SH) in adult (12/13 months) and old (24/25 months) IcoWI and WAG/Rij male rats. Old rats were untreated or treated for 3 months with melatonin (0.39 (IcoWi) and 0.44 (Wag/Rij) mg kg-1 day-1, drinking water). Stress-strain relationships were determined using cross-sectional area (CSA, microm2, histometry) and values of arteriolar internal diameter (microm) obtained during a second SH following arteriolar deactivation (EDTA, 67 mmol l(-1)). Aging induced (a) atrophy of the arteriolar wall in IcoWI (616+/-20 vs 500+/-27 microm2, P<0.05) but not in WAG/Rij rats (328+/-25 vs 341+/-20 microm2), (b) a decrease in arteriolar wall distensibility and (c) an increase in the LLCBF in both strains (67+/-10 mmHg in 12-month-old vs 95+/-6 mmHg in 24-month-old IcoWi, P<0.05 and 53+/-2 mmHg in 13-month-old vs 67+/-6 mmHg in 25-month-old WAG/Rij). Melatonin treatment induced in IcoWI and WAG/Rij rats (a) hypertrophy of the arteriolar wall (643+/-34 and 435+/-25 microm2, respectively), (b) an increase in arteriolar wall distensibility and (c) a decrease in the LLCBF (64+/-6 and 45+/-4 mmHg, respectively). Melatonin treatment of old rats induced hypertrophy of the arteriolar wall, prevented the age-linked decrease in cerebral arteriolar distensibility and decreased the LLCBF. British Journal of Pharmacology (2004) 141, 399-406. doi:10.1038/sj.bjp.0705629

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718260      PMCID: PMC1574212          DOI: 10.1038/sj.bjp.0705629

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

Review 1.  Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.

Authors:  A P Somlyo; A V Somlyo
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

Review 2.  Cerebrovascular structure and dementia: new drug targets.

Authors:  J Atkinson
Journal:  Trends Pharmacol Sci       Date:  2001-12       Impact factor: 14.819

3.  Effects of melatonin on rat pial arteriolar diameter in vivo.

Authors:  O Régrigny; P Delagrange; E Scalbert; I Lartaud-Idjouadiene; J Atkinson; J M Chillon
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

4.  Effects of aging on responses of cerebral arterioles.

Authors:  W G Mayhan; F M Faraci; G L Baumbach; D D Heistad
Journal:  Am J Physiol       Date:  1990-04

5.  Effects of aging on mechanics and composition of cerebral arterioles in rats.

Authors:  M A Hajdu; D D Heistad; J E Siems; G L Baumbach
Journal:  Circ Res       Date:  1990-06       Impact factor: 17.367

6.  Mechanics of cerebral arterioles in hypertensive rats.

Authors:  G L Baumbach; P B Dobrin; M N Hart; D D Heistad
Journal:  Circ Res       Date:  1988-01       Impact factor: 17.367

7.  Influence of vascular smooth muscle on contractile mechanics and elasticity of arteries.

Authors:  P B Dobrin; A A Rovick
Journal:  Am J Physiol       Date:  1969-12

Review 8.  Autoregulation of blood flow.

Authors:  P C Johnson
Journal:  Circ Res       Date:  1986-11       Impact factor: 17.367

9.  Melatonin increases pial artery tone and decreases the lower limit of cerebral blood flow autoregulation.

Authors:  O Régrigny; P Delagrange; E Scalbert; J Atkinson; J M Chillon
Journal:  Fundam Clin Pharmacol       Date:  2001-08       Impact factor: 2.748

10.  Cerebral blood flow in rats with renal and spontaneous hypertension: resetting of the lower limit of autoregulation.

Authors:  D I Barry; S Strandgaard; D I Graham; O Braendstrup; U G Svendsen; S Vorstrup; R Hemmingsen; T G Bolwig
Journal:  J Cereb Blood Flow Metab       Date:  1982-09       Impact factor: 6.200

View more
  4 in total

1.  Captopril improves cerebrovascular structure and function in old hypertensive rats.

Authors:  François Dupuis; Jeffrey Atkinson; Patrick Limiñana; Jean-Marc Chillon
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

Review 2.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

3.  The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injury.

Authors:  Juhyun Song; So Mang Kang; Won Taek Lee; Kyung Ah Park; Kyoung Min Lee; Jong Eun Lee
Journal:  Oxid Med Cell Longev       Date:  2014-07-14       Impact factor: 6.543

4.  Melatonin Treatment Regulates SIRT3 Expression in Early Brain Injury (EBI) Due to Reactive Oxygen Species (ROS) in a Mouse Model of Subarachnoid Hemorrhage (SAH).

Authors:  Song Yang; Xiuping Chen; Shengli Li; Bin Sun; Chunhua Hang
Journal:  Med Sci Monit       Date:  2018-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.